Abstract
Giant cell arteritis (GCA), also known as temporal arteritis, is a granulomatous vasculitis of medium- and large-sized arteries. GCA primarily involves the extracranial branches of the carotid artery and frequently affects the aorta and its major branches. Cranial ischemic complications, in particular permanent visual loss, constitute the most feared consequences of this disease. GCA is the most common form of systemic vasculitis in adults and preferentially occurs in the elderly. Understanding the arterial distribution of GCA is important in planning a diagnostic imaging study. For many years traditional arteriography was performed to look for the characteristic pattern and distribution of stenotic lesions that supported the diagnosis of GCA. Currently, that role has been replaced by computed tomographic angiography (CTA) and magnetic resonance angiography (MRA). Both exams are capable of producing excellent arterial displays and show increased arterial wall thickness of GCA. Diagnostic findings include segments of smooth narrowing alternating with normal caliber and increased wall thickness of the affected artery. Appearance will vary from patient to patient and with the phase of the disease process, acute or chronic. Acute disease in the arterial wall can be detected by MRA using a delayed enhancement sequence. Positron emission tomography (PET) scanning using 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) also detects acute disease. But MRA and PET images probably display different metabolic aspects of arterial inflammation. Ultrasound is an important diagnostic method for GCA. A lucent halo around the artery, wall thickening, and luminal narrowing are the diagnostic findings.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Achkar AA, Lie JT, Hunder GG et al (1994) How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 120(12):987–992
Agard C, Ponge T, Fradet G et al (2006) Giant cell arteritis presenting with aortic dissection: two cases and review of the literature. Scand J Rheumatol 35(3):233–236
Agard C, Barrier JH, Dupas B et al (2008) Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum 59(5):670–676
Aluquin VP, Albano SA, Chan F et al (2002) Magnetic resonance imaging in the diagnosis and follow up of Takayasu’s arteritis in children. Ann Rheum Dis 61(6):526–529
Amann-Vesti BR, Koppensteiner R, Rainoni L et al (2003) Immediate and long-term outcome of upper extremity balloon angioplasty in giant cell arteritis. J Endovasc Ther 10(2):371–375
Andrews J, Al-Nahhas A, Pennell DJ et al (2004) Non-invasive imaging in the diagnosis and management of Takayasu’s arteritis. Ann Rheum Dis 63(8):995–1000
Arida A, Kyprianou M, Kanakis M et al (2010) The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 11:44
Baril DT, Carroccio A, Palchik E et al (2006) Endovascular treatment of complicated aortic aneurysms in patients with underlying arteriopathies. Ann Vasc Surg 20(4):464–471
Bengtsson BA, Malmvall BE (1981) The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. Arthritis Rheum 24(7):899–904
Bley TA, Wieben O, Uhl M et al (2005) High-resolution MRI in giant cell arteritis: imaging of the wall of the superficial temporal artery. AJR Am J Roentgenol 184(1):283–287
Bley TA, Uhl M, Carew J et al (2007) Diagnostic value of high-resolution MR imaging in giant cell arteritis. AJNR Am J Neuroradiol 28(9):1722–1727
Blockmans D, Van Moer E, Dehem J et al (2002) Positron emission tomography can reveal abdominal periaortitis. Clin Nucl Med 27(3):211–212
Blockmans D, de Ceuninck L, Vanderschueren S et al (2006) Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 55(1):131–137
Blockmans D, Coudyzer W, Vanderschueren S et al (2008) Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) 47(8):1179–1184
Bongartz T, Matteson EL (2006) Large-vessel involvement in giant cell arteritis. Curr Opin Rheumatol 18(1):10–17
Both M, Aries PM, Muller-Hulsbeck S et al (2006) Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis. Ann Rheum Dis 65(9):1124–1130
Both M, Ahmadi-Simab K, Reuter M et al (2008) MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis 67(7):1030–1033
Brack A, Martinez-Taboada V, Stanson A et al (1999) Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 42(2):311–317
Brodmann M, Lipp RW, Passath A et al (2004) The role of 2-18F-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. Rheumatology (Oxford) 43(2):241–242
Chan CC, Paine M, O’Day J (2001) Steroid management in giant cell arteritis. Br J Ophthalmol 85(9):1061–1064
Choe YH, Lee WR (1998) Magnetic resonance imaging diagnosis of Takayasu arteritis. Int J Cardiol 66(Suppl 1):S175–S179 discussion S181
Choe YH, Kim DK, Koh EM et al (1999) Takayasu arteritis: diagnosis with MR imaging and MR angiography in acute and chronic active stages. J Magn Reson Imaging 10(5):751–757
Dellaripa PF, Eisenhauer AC (1998) Bilateral percutaneous balloon angioplasty of the axillary arteries in a patient with giant cell arteritis and upper extremity ischemic symptoms not responsive to corticosteroids. J Rheumatol 25(7):1429–1433
Deng J, Younge BR, Olshen RA et al (2010) Th17 and Th1 T-cell responses in giant cell arteritis. Circulation 121(7):906–915
Derdelinckx I, Maes A, Bogaert J et al (2000) Positron emission tomography scan in the diagnosis and follow-up of aortitis of the thoracic aorta. Acta Cardiol 55(3):193–195
Desai MY, Stone JH, Foo TK et al (2005) Delayed contrast-enhanced MRI of the aortic wall in Takayasu’s arteritis: initial experience. AJR Am J Roentgenol 184(5):1427–1431
Evans JM, O’Fallon WM, Hunder GG (1995) Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis. A population-based study. Ann Intern Med 122(7):502–507
Geiger J, Bley T, Uhl M et al (2010) Diagnostic value of T2-weighted imaging for the detection of superficial cranial artery inflammation in giant cell arteritis. J Magn Reson Imaging 31(2):470–474
Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ et al (2001) Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 60(4):367–371
Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C et al (2003) Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 33(1):38–48
Gotway MB, Araoz PA, Macedo TA et al (2005) Imaging findings in Takayasu’s arteritis. AJR Am J Roentgenol 184(6):1945–1950
Haider CR, Glockner JF, Stanson AW et al (2009) Peripheral vasculature: high-temporal- and high-spatial-resolution three-dimensional contrast-enhanced MR angiography. Radiology 253(3):831–843
Hara M, Goodman PC, Leder RA (1999) FDG-PET finding in early-phase Takayasu arteritis. J Comput Assist Tomogr 23(1):16–18
Hayashida T, Sueyoshi E, Sakamoto I et al (2010) PET features of aortic diseases. AJR Am J Roentgenol 195(1):229–233
Herve F, Choussy V, Janvresse A et al (2006) Aortic involvement in giant cell arteritis. A prospective follow-up of 11 patients using computed tomography. Rev Med Interne 27(3):196–202
Hoffman GS, Cid MC, Rendt-Zagar KE et al (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146(9):621–630
Hunder GG, Sheps SG, Allen GL et al (1975) Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study. Ann Intern Med 82(5):613–618
Hunder GG, Bloch DA, Michel BA et al (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 33(8):1122–1128
Karassa FB, Matsagas MI, Schmidt WA et al (2005) Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 142(5):359–369
Keenan NG, Mason JC, Maceira A et al (2009) Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum 60(11):3501–3509
Kermani TA, Matteson EL, Hunder GG et al (2009) Symptomatic lower extremity vasculitis in giant cell arteritis: a case series. J Rheumatol 36(10):2277–2283
Kermani TA, Schafer VS, Crowson CS et al (2010) Increase in age at onset of giant cell arteritis: a population-based study. Ann Rheum Dis 69(4):780–781
Klein RG, Hunder GG, Stanson AW et al (1975) Large artery involvement in giant cell (temporal) arteritis. Ann Intern Med 83(6):806–812
Kobayashi S, Yano T, Matsumoto Y et al (2003) Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 49(4):594–598
Lee MS, Smith SD, Galor A et al (2006) Antiplatelet and anticoagulant therapy in patients with giant cell arteritis. Arthritis Rheum 54(10):3306–3309
Mahr AD, Jover JA, Spiera RF et al (2007) Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum 56(8):2789–2797
Marie I, Proux A, Duhaut P et al (2009) Long-term follow-up of aortic involvement in giant cell arteritis: a series of 48 patients. Medicine (Baltimore) 88(3):182–192
Narvaez J, Narvaez JA, Nolla JM et al (2005) Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. Rheumatology (Oxford) 44(4):479–483
Nesher G, Berkun Y, Mates M et al (2004) Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis. Arthritis Rheum 50(4):1332–1337
Nordborg E, Bengtsson BA (1990) Epidemiology of biopsy-proven giant cell arteritis (GCA). J Intern Med 227(4):233–236
Nuenninghoff DM, Hunder GG, Christianson TJ et al (2003a) Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48(12):3522–3531
Nuenninghoff DM, Hunder GG, Christianson TJ et al (2003b) Mortality of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 48(12):3532–3537
Parikh M, Miller NR, Lee AG et al (2006) Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Ophthalmology 113(10):1842–1845
Piggott K, Biousse V, Newman NJ et al (2009) Vascular damage in giant cell arteritis. Autoimmunity 42(7):596–604
Pipitone N, Salvarani C (2008) Improving therapeutic options for patients with giant cell arteritis. Curr Opin Rheumatol 20(1):17–22
Pipitone N, Versari A, Salvarani C (2008) Role of imaging studies in the diagnosis and follow-up of large-vessel vasculitis: an update. Rheumatology (Oxford) 47(4):403–408
Ray-Chaudhuri N, Kine DA, Tijani SO et al (2002) Effect of prior steroid treatment on temporal artery biopsy findings in giant cell arteritis. Br J Ophthalmol 86(5):530–532
Reinhard M, Schmidt D, Hetzel A (2004) Color-coded sonography in suspected temporal arteritis-experiences after 83 cases. Rheumatol Int 24(6):340–346
Rits Y, Oderich GS, Bower TC et al (2010) Interventions for mesenteric vasculitis. J Vasc Surg 51(2):392–400e2
Salvarani C, Hunder GG (2001) Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum 45(2):140–145
Salvarani C, Macchioni P, Zizzi F et al (1991) Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 34(3):351–356
Salvarani C, Gabriel SE, O’Fallon WM et al (1995) The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 123(3):192–194
Salvarani C, Cantini F, Boiardi L et al (2002) Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med 347(4):261–271
Salvarani C, Cantini F, Hunder GG (2008) Polymyalgia rheumatica and giant-cell arteritis. Lancet 372(9634):234–245
Salvarani C, Della Bella C, Cimino L et al (2009) Risk factors for severe cranial ischaemic events in an Italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 48(3):250–253
Schafer VS, Warrington KJ, Williamson EE et al (2009) Delayed diagnosis of biopsy-negative giant cell arteritis presenting as fever of unknown origin. J Gen Intern Med 24(4):532–536
Scheel AK, Meller J, Vosshenrich R et al (2004) Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis 63(11):1507–1510
Schmidt WA, Kraft HE, Vorpahl K et al (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337(19):1336–1342
Schmidt WA, Seifert A, Gromnica-Ihle E et al (2008) Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology (Oxford) 47(1):96–101
Short RF, Sabri SS, Angle JF et al (2009) Endovascular intervention for extracranial manifestations of giant cell arteritis: 12 year institutional experience. J Vasc Interv Radiol 20(2):S27 Abstract No. 65
Smetana GW, Shmerling RH (2002) Does this patient have temporal arteritis? JAMA 287(1):92–101
Stanson AW (2000) Imaging findings in extracranial (giant cell) temporal arteritis. Clin Exp Rheumatol 18(4 Suppl 20):S43–S48
Stanson AW, Klein RG, Hunder GG (1976) Extracranial angiographic findings in giant cell (temporal) arteritis. AJR Am J Roentgenol 127(6):957–963
Sueyoshi E, Sakamoto I, Uetani M (2006) MRI of Takayasu’s arteritis: typical appearances and complications. AJR Am J Roentgenol 187(6):W569–W575
Sujobert P, Fardet L, Marie I et al (2007) Mesenteric ischemia in giant cell arteritis: 6 cases and a systematic review. J Rheumatol 34(8):1727–1732
Tso E, Flamm SD, White RD et al (2002) Takayasu arteritis: utility and limitations of magnetic resonance imaging in diagnosis and treatment. Arthritis Rheum 46(6):1634–1642
Warrington KJ, Matteson EL (2007) Management guidelines and outcome measures in giant cell arteritis (GCA). Clin Exp Rheumatol 25(6 Suppl 47):137–141
Webb M, Chambers A, L-N AA et al (2004) The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis. Eur J Nucl Med Mol Imaging 31(5):627–634
Weyand CM, Goronzy JJ (2003) Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 139(6):505–515
Weyand CM, Hicok KC, Hunder GG et al (1992) The HLA-DRB1 locus as a genetic component in giant cell arteritis. Mapping of a disease-linked sequence motif to the antigen binding site of the HLA-DR molecule. J Clin Invest 90(6):2355–2361
Weyand CM, Ma-Krupa W, Goronzy JJ (2004) Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 3(1):46–53
Weyand CM, Ma-Krupa W, Pryshchep O et al (2005) Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 1062:195–208
Yamada I, Nakagawa T, Himeno Y et al (2000) Takayasu arteritis: diagnosis with breath-hold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging 11(5):481–487
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fleming, C.J., Warrington, K.J., Glockner, J., Miller, D.V., Friese, J.L., Stanson, A.W. (2011). Giant Cell Arteritis. In: Hendaoui, L., Stanson, A., Bouhaouala, M., Joffre, F. (eds) Systemic Vasculitis. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2011_147
Download citation
DOI: https://doi.org/10.1007/174_2011_147
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02483-2
Online ISBN: 978-3-642-02484-9
eBook Packages: MedicineMedicine (R0)